Stay updated with breaking news from ஜிம் ரோட்டோலோ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Got summer plans? Bruce Springsteen does. He s restaging his hit “Springsteen on Broadway” starting Saturday, June 26, at the St. James Theatre. The Boss initially planned to take the summer off as he s going back out on the road with the E Street Band next year, he said to Jim Rotolo of SiriusXM s E Street Radio on Thursday, June 10, but the opportunity presented itself. “It gives me something to do this summer so I won’t be lazying around on the beach,” Springsteen said. “I knew we were going to tour with the band next year so I said I ll take some time off.” ....
Bruce Springsteen called in to his SiriusXM channel E Street Radio today to talk about his return to Broadway with SiriusXM hosts Dave Marsh and Jim Rotolo. ‘Springsteen On Broadway’ will return this summer for a limited run of performances at New York City’s St. James Theatre. Shows begin June 26 with additional performances through September 4. ....
/PRNewswire/ Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult to. ....
Sapience Therapeutics Awarded SBIR Phase I Grant from National Institute of Allergy and Infectious Diseases News provided by Share this article Share this article HARRISON, N.Y., May 18, 2021 /PRNewswire/ Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult to treat oncology indications, announced today that it was awarded a Small Business Innovative Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to investigate the inhibition of SARS-CoV-2 infection with a pan-coronavirus anti-viral peptide. The grant will provide funds over two years to support the discovery and development of peptide therapeutics against coronaviruses, including SARS-CoV-2 (COVID-19). ....
Sapience Therapeutics Awarded SBIR Phase I Grant from National Institute of Allergy and Infectious Diseases prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.